Yigal Nochomovitz

Stock Analyst at Citigroup

(2.32)
# 2,561
Out of 5,180 analysts
336
Total ratings
40.74%
Success rate
-1.88%
Average return

Stocks Rated by Yigal Nochomovitz

Biomea Fusion
Mar 27, 2026
Maintains: Buy
Price Target: $6$7
Current: $1.32
Upside: +430.30%
LENZ Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $52$26
Current: $8.40
Upside: +209.52%
Sarepta Therapeutics
Mar 26, 2026
Maintains: Sell
Price Target: $9$13
Current: $19.97
Upside: -34.90%
Ligand Pharmaceuticals
Mar 24, 2026
Maintains: Buy
Price Target: $270$276
Current: $195.48
Upside: +41.19%
Arvinas
Mar 19, 2026
Maintains: Buy
Price Target: $18$21
Current: $10.10
Upside: +107.92%
Candel Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $22$26
Current: $4.81
Upside: +440.54%
Zenas BioPharma
Mar 17, 2026
Maintains: Buy
Price Target: $43$41
Current: $18.21
Upside: +125.15%
Olema Pharmaceuticals
Mar 17, 2026
Maintains: Buy
Price Target: $60$62
Current: $13.67
Upside: +353.55%
Shattuck Labs
Mar 13, 2026
Maintains: Neutral
Price Target: $4$7
Current: $6.02
Upside: +16.28%
Alpha Tau Medical
Mar 11, 2026
Maintains: Buy
Price Target: $7$9
Current: $6.86
Upside: +31.20%
Maintains: Buy
Price Target: $2.1$2.3
Current: $1.65
Upside: +39.39%
Maintains: Buy
Price Target: $31$35
Current: $12.50
Upside: +180.00%
Maintains: Buy
Price Target: $31$33
Current: $21.46
Upside: +53.77%
Maintains: Buy
Price Target: $44$45
Current: $20.28
Upside: +121.89%
Maintains: Neutral
Price Target: $7$8
Current: $6.76
Upside: +18.34%
Initiates: Buy
Price Target: $42
Current: $22.61
Upside: +85.76%
Maintains: Buy
Price Target: $51$57
Current: $23.49
Upside: +142.66%
Maintains: Buy
Price Target: $45$44
Current: $16.97
Upside: +159.28%
Maintains: Buy
Price Target: $16$17
Current: $12.06
Upside: +40.96%
Maintains: Buy
Price Target: $64$65
Current: $30.46
Upside: +113.39%
Maintains: Buy
Price Target: $336$371
Current: $245.39
Upside: +51.19%
Maintains: Buy
Price Target: $203$204
Current: $128.32
Upside: +58.98%
Maintains: Buy
Price Target: $11$14
Current: $5.48
Upside: +155.47%
Maintains: Buy
Price Target: $33$36
Current: $20.75
Upside: +73.49%
Maintains: Buy
Price Target: $87$77
Current: $45.75
Upside: +68.31%
Maintains: Buy
Price Target: $399$405
Current: $283.03
Upside: +43.09%
Maintains: Buy
Price Target: $16$14
Current: $7.11
Upside: +96.91%
Maintains: Buy
Price Target: $5$8
Current: $1.78
Upside: +349.44%
Maintains: Buy
Price Target: $35$40
Current: $16.58
Upside: +141.25%
Maintains: Buy
Price Target: $66$69
Current: $18.00
Upside: +283.33%
Maintains: Buy
Price Target: $19$22
Current: $24.18
Upside: -9.02%
Maintains: Buy
Price Target: $6$9
Current: $1.60
Upside: +462.50%
Maintains: Buy
Price Target: $49$55
Current: $25.84
Upside: +112.85%
Maintains: Buy
Price Target: $16$14
Current: $2.93
Upside: +377.82%
Maintains: Neutral
Price Target: $3.5$1.2
Current: $2.30
Upside: -47.83%
Maintains: Neutral
Price Target: $1.8$2
Current: $1.37
Upside: +45.99%
Maintains: Buy
Price Target: $25$8
Current: $1.77
Upside: +351.98%
Maintains: Neutral
Price Target: $1.5$1
Current: $2.75
Upside: -63.64%
Maintains: Sell
Price Target: $50$35
Current: $4.59
Upside: +662.53%
Maintains: Buy
Price Target: $130$133
Current: $19.38
Upside: +586.27%
Maintains: Buy
Price Target: $24$16
Current: $3.08
Upside: +419.48%
Maintains: Buy
Price Target: $9$10
Current: $1.17
Upside: +754.70%
Maintains: Buy
Price Target: $16$12
Current: $1.30
Upside: +823.08%
Upgrades: Buy
Price Target: n/a
Current: $6.08
Upside: -